NFKB1 and metabolic syndrome: Mechanistically, dyslipidemia drives plaque instability via oxidative modification of small dense LDL particles, which activate NF-κB-mediated endothelial inflammation and foam cell formation (Hasheminasabgorji and Jha, 2021; Higashi, 2023).